Volume 39, Issue 6 pp. 712-723
Original Article
Full Access

A β-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome

Dr Christopher M. Gomez MD, PhD

Corresponding Author

Dr Christopher M. Gomez MD, PhD

Depart of Neurology, University of Minnesota, Minneapolis, MN

Department of neurology University of Minnesota, 420 Delaware St SE, Minneapolis, MN 55455Search for more papers by this author
Ricardo Maselli MD

Ricardo Maselli MD

Sections of Neuroscience, University of California-Davis, Davis, CA

Search for more papers by this author
Jason Gammack BS

Jason Gammack BS

Depart of Neurology, University of Minnesota, Minneapolis, MN

Search for more papers by this author
Jose Lasalde PhD

Jose Lasalde PhD

Sections of Molecular and Cellular Biology, University of California-Davis, Davis, CA

Search for more papers by this author
Shiori Tamamizu PhD

Shiori Tamamizu PhD

Sections of Molecular and Cellular Biology, University of California-Davis, Davis, CA

Search for more papers by this author
David R. Cornblath

David R. Cornblath

Department of Neurology, Johns Hopkins Hospital, Baltimore, MD

Search for more papers by this author
Mohamed Lehar MD

Mohamed Lehar MD

Department of Neurology, Johns Hopkins Hospital, Baltimore, MD

Search for more papers by this author
Mark McNamee PhD

Mark McNamee PhD

Sections of Molecular and Cellular Biology, University of California-Davis, Davis, CA

Search for more papers by this author
Ralph W. Kuncl MD, PhD

Ralph W. Kuncl MD, PhD

Department of Neurology, Johns Hopkins Hospital, Baltimore, MD

Search for more papers by this author
First published: June 1996
Citations: 86

Abstract

Point mutations in the genes encoding the acetylcholine receptor (AChR) subunits have been recognized in some patients with slow-channel congenital myasthenic syndromes (CMS). Clinical, electrophysiological, and pathological differences between these patients may be due to the distinct effects of individual mutations. We report that a spontaneous mutation of the β subunit that interrupts the leucine ring of the AChR channel gate causes an eightfold increase in channel open time and a severe CMS characterized by severe endplate myopathy and extensive remodeling of the postsynaptic membrane. The pronounced abnormalities in neuromuscular synaptic architecture and function, muscle fiber damage and weakness, resulting from a single point mutation are a dramatic example of a mutation having a dominant gain of function and of hereditary excitotoxicity.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me